Researcher interests: Genetic aspects of neoplastic transformation. Molecular mimicry of glycosaminoglycans by synthetic compounds. Selected topics in tissue dynamics; apoptosis and angiogenesis, in particular.
FACULTY / SCHOOL: School of Medicine - IMRIC
DEPARTMENT: Developmental Biology and Cancer Research
Selected Publications
curcumin protects skin against uvb induced cytotoxicity via the keap1 nrf2 pathway the use of a microemulsion delivery system (2017)|
Oxidative Medicine and Cellular Longevity|
Read more
skin redox balance maintenance the need for an nrf2 activators delivery system (2016)|
Journal of the International Society of Antioxidants in Nutrition & Health|
Read more
identification of tissue specific cell death using methylation patterns of circulating dna (2016)|
Proceedings of the National Academy of Sciences of the United States of America|
Read more
nitroxide delivery system for nrf2 activation and skin protection (2015)|
European Journal of Pharmaceutics and Biopharmaceutics|
Read more
can nitroxides evoke the keap1 nrf2 are pathway in skin (2014)|
Free Radical Biology and Medicine|
Read more
metabolic aging in diabetes the glucoliptoxic connection (2013)|
Free Radical Biology and Medicine|
Read more
a new method for encapsulating hydrophobic compounds within cationic polymeric nanoparticles (2013)|
Journal of Microencapsulation|
Read more
macrovascular endothelial cell senescence is induced by foam cell derived lipid peroxidation products (2012)|
Free Radical Biology and Medicine|
Read more
cell pairing and methylation in tetrahymena thermophila are altered by exogenous homocysteine (1999)|
Cell Biology International|
Read more
Success Stories & related Product & PR
Raziel Therapeutics
Raziel Therapeutics is a clinical-stage pharmaceutical company developing a proprietary drug for the treatment of local fat reduction. The company is targeting obesity and related indications.
TILTAN PHARMA LTD.
Tiltan Pharma’s proprietary anti-cancer platform is based on a combination of agents that target different, non-overlapping aspects of the angiogenic process. All of these agents are orally bio-available and FDA approved. The therapy cycle is a...
